# Smith & Nephew Plc (SNN)

Source page: https://stoqly.net/companies/snn

- **Ticker:** SNN (NYSE)
- **Sector:** Health Care / Orthopedic, Prosthetic & Surgical Appliances & Supplies
- **SEC CIK:** 0000845982
- **Latest annual report:** 20-F filed 2026-03-16 (https://www.sec.gov/Archives/edgar/data/845982/000110465926028258/snn-20251231x20f.htm)
- **Data updated:** 2026-11-01

## Key figures

- **Last close:** $29.70 on 2026-10-30
- **Market cap:** $13.0B
- **P/E (trailing):** 20.7x
- **EPS, trailing 12 months:** $1.43
- **Revenue (FY2025):** $6.2B
- **Revenue growth:** +6.1%
- **Revenue growth, 5-year CAGR:** +6.2%
- **Gross margin:** 68.0%
- **Operating margin:** 12.9%
- **Net margin:** 10.1%
- **Return on invested capital:** 8.1%
- **Return on equity:** 11.8%
- **Net debt:** $2.6B
- **Change in share count:** −0.3%
- **Piotroski F-score:** 7/9
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.0M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/snn/figures.csv

| US$ millions | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|
| Revenue | 4,669 | 4,765 | 4,904 | 5,138 | 4,560 | 5,212 | 5,215 | 5,549 | 5,810 | 6,164 |
| Operating income | 801 | 934 | 863 | 815 | 295 | 593 | 450 | 425 | 657 | 794 |
| Net income | 784 | 767 | 663 | 600 | 448 | 524 | 223 | 263 | 412 | 625 |
| Diluted EPS (US$) | 1.76 | 1.75 | 151.40 | 1.19 | 1.02 | 1.19 | 0.51 | 0.60 | 0.94 | 1.43 |
| Operating cash flow | 849 | 1,090 | 931 | 1,168 | 935 | 877 | 468 | 608 | 987 | 1,285 |
| Cash | 38 | 155 | 333 | 257 | 1,751 | 1,285 | 350 | 302 | 619 | 557 |
| Debt and leases | 1,650 | 1,450 | 1,465 | 1,877 | 3,486 | 3,142 | 2,676 | 2,885 | 3,125 | 3,111 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.